Rimonabant Acomplia Helps With Weight Loss

Rimonabant Acomplia is an anorectic anti obesity drug. It is a CB1 cannabinoid receptor antagonist. Its main avenue of effect is reduction in appetite. Obesity is now the most common nutritional disorder in western countries. Defined as a body mass index of greater than 30, it arises from the accumulation of excess fat in the body from overconsumption of fatty foods. Prevalence of obesity in the US and Europe has reached epidemic levels. Data from the World Health Organisation’s MONICA project show that in some parts of Europe over 70% of men aged 55-64 years are clinically obese or overweight (BMI >25) and almost 70% of women in this age group. One in five of all Americans is obese and one in three overweight. Furthermore, increasing rates of childhood obesity are likely to exacerbate the trend towards increasing obesity in adulthood.

How much weight can I lose by taking Acomplia?

Exhaustive clinical trials conducted with Acomplia on more than 6800 patients yielded substantial results. Patients given Acomplia for a period of one year achieved an average weight loss of six and half kg as compared to just over one and half kg achieved by those on placebo. Most of the weight loss was achieved in the first 9 months of the trial with Acomplia.

Acomplia was also found to reduce the risk of regaining weight. When a group of patients from one of the clinical trials was re-randomized and split into Acomplia and placebo groups, those patients who continued on Acomplia achieved a total weight loss of 7.5 kg over the two year trial period. On the other hand patients who were transferred to placebo achieved a much lower weight loss of only 3.1 kg over the same period.

The best part about Acomplia diet pills is that it brings about sizeable reduction in the waist circumference – nearly 6 to 7 cm on an average. This measure is an indication of intra-abdominal fat and is believed to be more important that BMI. If you have a large waist circumference, you should buy Acomplia for reducing it.

Are there any contraindications for the use of Acomplia?

While Acomplia is safe for use in most patients, it should be used with caution in patients with the following conditions:

• Moderate kidney or urological system problems
• Epilepsy
• Patients on ketoconazole, itraconazole, ritonavir, telithromycin, or clarithromycin
• The rare hereditary problem of galactose intolerance

Patients who have the following ailments should not buy Acomplia:

• Chronic kidney or urological problems
• Serious psychiatric illness such as major depression
• Suffered a cardiovascular event like myocardial infarction less than six months ago
• Pregnant and breastfeeding women

Who should take Acomplia?

Acomplia is a prescription only medication and you should buy Acomplia only after consultation and prescription from a registered medical practitioner. Acomplia should never be considered as an alternative to diet and exercise for weight loss and should only be used as an adjunct for the treatment of obesity. Acomplia is generally prescribed to patients with a BMI of 30 or more or to overweight patients with a BMI of 27 with additional risk factors like type-2 diabetes or dyslipidaemia. Only one 20 mg tablet of Acomplia should be taken every morning with breakfast.

All orders for Acomplia received before 3:00 pm Monday to Friday are dispatched same day for next day delivery.

Acomplia (rimonabant) is only licensed for weight loss and obesity treatment in the UK and Europe. It is a prescription medication and so we strongly advise patients to seek a face to face consultation with your doctor before you buy Acomplia from www.rimonabant-acompliac.co.uk.
You should not consider our online consultation as a replacement for the treatment advice of your doctor.